Skip to main content

Table 3 Meta-analysis results of the association of C677T polymorphisms and HCC of 4 studies (including CLD controls)

From: Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis

Genetic model

OR

95%CI

p for herterogeneity

I2

Egger's p

TT/CC (OR1)

1.72

0.84-3.52

0.04

0.64

0.69

CT/CC (OR2)

0.85

0.62-1.16

0.82

0

0.44

TT/CT (OR3)

1.81

1.22-2.71

0.25

0.28

0.71

(TT+CT)/CC

1.03

0.77-1.36

0.13

0.46

0.26

TT/(CC+CT)

1.85

1.00-3.42

0.06

0.60

0.78

CT/(CC+TT)

0.75

0.57-0.99

0.92

0

0.68

T/C

1.31

0.86-2.02

0.01

0.76

0.25